Biosimilars: A Comparative Study of Regulatory, Safety and Pharmacovigilance Monograph in the Developed and Developing Economies
Epitomizing one of the rapidly maturing segments of pharmaceutical industry, biologics gestalt has severely implicated treatment algorithms of many life-threatening diseases especially in oncology, immunology, diabetes, and irresistible infections through integration of biologics in the clinical pr...
Main Authors: | Zarina Iqbal, Saima Sadaf |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/32433 |
Similar Items
-
Biologicals and Biosimilars: Gaps in the Pharmacovigilance System in Portugal
by: Maria da Conceição Constantino Portela, et al.
Published: (2017-03-01) -
Regulatory considerations for biosimilars
by: Ranjani Nellore
Published: (2010-01-01) -
An Overview of Biosimilars—Development, Quality, Regulatory Issues, and Management in Healthcare
by: Filipa Mascarenhas-Melo, et al.
Published: (2024-02-01) -
Ten years of biosimilars in Europe: development and evolution of the regulatory pathways
by: Schiestl M, et al.
Published: (2017-05-01) -
Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)